Aktieselskabet Schouw & Co.
Schouw & Co. share buy-back programme, week 12 2025
Schouw & Co. share buy-back programme, week 12 2025
On 2 January 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 70 of 23 December 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 50 million during the period 2 January to 31 March 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
Trading day | No. of shares | Average price | Amount | ||
Accumulated until 14 March 2025 | 76,600 | 561.16 | 42,984,732 | ||
Monday, 17 March 2025 | 900 | 646.29 | 581,661 | ||
Tuesday, 18 March 2025 | 900 | 654.06 | 588,654 | ||
Wednesday, 19 March 2025 | 900 | 650.31 | 585,279 | ||
Thursday, 20 March 2025 | 1,000 | 651.67 | 651,670 | ||
Friday, 21 March 2025 | 1,000 | 638.92 | 638,920 | ||
In the period 17 March 2025 - 21 March 2025 | 4,700 | 648.12 | 3,046,184 | ||
Accumulated until 21 March 2025 | 81,300 | 566.19 | 46,030,916 | ||
Following the above transactions, Schouw & Co. holds a total of 2,035,713 treasury shares corresponding to 8.14% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd30.6.2025 07:00:00 CEST | Press release
Changes to the Roche Enlarged Corporate Executive Committee
Idorsia Pharmaceuticals Ltd30.6.2025 07:00:00 CEST | Press release
A factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humans
Sanofi Winthrop Industrie30.6.2025 07:00:00 CEST | Press release
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
Bitget Limited30.6.2025 06:37:53 CEST | Press release
Bitget Launchpool to List Fragmetric (FRAG) with 4.6 Million Tokens in Rewards
Caseware30.6.2025 03:00:00 CEST | Press release
Caseware Launches Cloud Audit – A Next-Generation Solution for Singapore’s Audit Professionals
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom